ストックスクリーナーアプリを入手
133.61
0.43%
-0.58
プレマーケット:
128.00
-5.61
-4.20%
Illumina Inc (ILMN) 最新ニュース
Illumina revenue up 5% to USD 1.16B in Q4 2025 - Medical Buyer
ILMN Q4 Deep Dive: Clinical Consumables Growth, Multiomics Expansion, and Margin Momentum - Yahoo Finance
Illumina Q4 Earnings Call Highlights - Yahoo Finance
Illumina (ILMN) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance Singapore
Illumina Q4 2025 slides: Clinical growth accelerates as NovaSeq X transition advances - Investing.com
Illumina Inc (NASDAQ:ILMN) Stock Falls Despite Q4 Earnings Beat on Cautious 2026 Outlook - Chartmill
Earnings call transcript: Illumina beats Q4 2025 EPS forecast by 10.66% - Investing.com India
Illumina (ILMN) Tops Q4 Earnings and Revenue Estimates - Nasdaq
Illumina: Q4 Earnings Snapshot - kens5.com
Illumina shares tumble as flat revenue disappoints investors By Investing.com - Investing.com
Illumina Inc. Q4 Profit Advances - Nasdaq
Illumina Q4 Non-GAAP Earnings, Revenue Rise; 2026 Outlook Set - marketscreener.com
Illumina (NASDAQ:ILMN) Reports Bullish Q4 CY2025 - TradingView
Illumina Q4 Earnings Summary & Key Takeaways - Benzinga
Earnings Flash (ILMN) Illumina, Inc. Reports Q4 Revenue $1.16B, vs. FactSet Est of $1.12B - marketscreener.com
Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2025 - PR Newswire
Illumina earnings loom as investors seek clarity on 2026 outlook By Investing.com - au.investing.com
Insights Into Illumina (ILMN) Q4: Wall Street Projections for Key Metrics - Yahoo Finance
Multi-Omics Market Set for Explosive Growth to USD 33.25 Billion - openPR.com
San Diego Zoo’s Frozen Zoo Gets Genomic Boost - 101.5 KGB
Synthetic Biology Market Set for Explosive Growth to USD 67.47 - openPR.com
Mediolanum International Funds Ltd Makes New $914,000 Investment in Illumina, Inc. $ILMN - MarketBeat
Illumina (ILMN) Reports Q4: Everything You Need To Know Ahead Of Earnings - Yahoo Finance
What Catalysts Are Shifting The Illumina (ILMN) Story For 2026 And Beyond - Yahoo Finance
Illumina, Inc. and the San Diego Zoo Wildlife Alliance Partner to Sequence the Frozen Zoo - marketscreener.com
Illumina Partners with San Diego Zoo for Genomic Sequencing of Endangered Species - Intellectia AI
Illumina and the San Diego Zoo Wildlife Alliance partner to sequence the Frozen Zoo®, supporting critical conservation genetics efforts globally - PR Newswire
WCM Investment Management LLC Has $384.17 Million Position in Illumina, Inc. $ILMN - MarketBeat
Bioinformatics Market to Witness Massive Growth by 2033: - openPR.com
Mapping the future of whole-genome sequencing with Illumina constellation technology - Illumina
Video: UK Festival of Genomics & Biodata 2026 - Illumina
PacBio sells short-read DNA sequencing assets to Illumina for $48.1m - Investing.com Canada
Pacific Biosciences of California Closes $48.1 Million Sale of DNA Sequencing Assets to Illumina - marketscreener.com
PacBio (PACB) Finalizes Asset Sale to Illumina, Secures $48.1 Mi - GuruFocus
Illumina completes acquisition of SomaLogic - marketscreener.com
Illumina buys SomaLogic in bid to expand proteomics reach - The Pharma Letter
ILMN Q4 Earnings Preview: NovaSeq X Momentum Likely to Aid Performance - TradingView
Pacific Biosciences of California Signs Asset Purchase Agreement With Illumina Cambridge - TradingView
Does CMS Backing of TruSight Oncology Recast Illumina’s (ILMN) Clinical Genomics Potential? - simplywall.st
PacBio Completes Sale of Short-Read Sequencing Assets to Illumina for $48.1 Million - Quiver Quantitative
Illumina acquires SomaLogic - Medical Buyer
Thrivent Financial for Lutherans Sells 38,212 Shares of Illumina, Inc. $ILMN - MarketBeat
Exosome Research Market to Witness Stunning Growth 2026-2033 - openPR.com
DNA Sequencing Market Covering Prime Factors and Competitive - openPR.com
Y Intercept Hong Kong Ltd Cuts Stock Position in Illumina, Inc. $ILMN - MarketBeat
Cancer Biopsy Market Set for Rapid Growth and Trend by 2026-2033 - openPR.com
Illumina, Inc. $ILMN Position Trimmed by AE Wealth Management LLC - MarketBeat
Metagenomic Sequencing Market to Reach US$ 9.25 Billion by 2033 - openPR.com
Assessing Illumina (ILMN) Valuation As Shares Rebound But Long Term Returns Remain Under Pressure - Yahoo Finance
Can Illumina Inc stock outperform in a bear marketJuly 2025 PostEarnings & Verified Swing Trading Watchlists - baoquankhu1.vn
Understanding the Setup: (ILMN) and Scalable Risk - Stock Traders Daily
Illumina, Inc. $ILMN Position Reduced by Bank of New York Mellon Corp - MarketBeat
Keybank National Association OH Purchases 60,375 Shares of Illumina, Inc. $ILMN - MarketBeat
Standard BioTools completes sale of SomaLogic to Illumina for $350 million - Investing.com Nigeria
Boulder biotech SomaLogic acquired in deal worth up to $425M - The Business Journals
Standard BioTools Completes Sale of SomaLogic to Illumina - Investing News Network
Illumina completes acquisition of SomaLogic for $350 million By Investing.com - Investing.com Canada
Illumina completes acquisition of SomaLogic for $350 million - Investing.com
Standard BioTools Inc. Completes $350 Million Sale of SomaLogic to Illumina, Enhancing Financial Position for Growth Strategy - Quiver Quantitative
Illumina (NASDAQ: ILMN) completes $350M SomaLogic proteomics deal - Stock Titan
1.62%
1.94%
大文字化:
|
ボリューム (24 時間):